AristaMD is a Healthtech company based in Cranbury, NJ. It has raised $20M in total funding. Latest round: Series C.
AristaMD funding overview
AristaMD is a Healthtech company based in Cranbury, NJ. AristaMD has raised $20M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series C announced in November 2023. The round record for AristaMD runs through 2023; nothing later has been disclosed. Investors on record include Cigna Ventures, MemorialCare Innovation Fund, Avalon Ventures, CU Healthcare Innovation Fund, Stanford Health Care. 5 distinct backers are named across the disclosed rounds.
AristaMD at a glance
Total raised
$20M
Latest round
Series C
Latest round date
November 2023
Industry
Healthtech
Headquarters
Cranbury, NJ
Notable investors
Cigna Ventures, MemorialCare Innovation Fund, Avalon Ventures, CU Healthcare Innovation Fund, Stanford Health Care
Frequently asked about AristaMD funding
How much has AristaMD raised?
AristaMD has raised $20M in total disclosed funding across the rounds on record.
Who has invested in AristaMD?
Cigna Ventures, MemorialCare Innovation Fund, Avalon Ventures, CU Healthcare Innovation Fund, Stanford Health Care are named among the investors backing AristaMD.
What was the latest AristaMD funding round?
The most recent disclosed round is a Series C, announced in November 2023.
Where is AristaMD based?
AristaMD is based in Cranbury, NJ.
What sector does AristaMD operate in?
AristaMD is tracked under Healthtech from Cranbury, NJ, with $20M in disclosed funding.
When did AristaMD last raise?
The last disclosed AristaMD round closed in November 2023 at Series C.
Totals shown for AristaMD aggregate every disclosed round on file. To see how that compares, browse the Healthtech companies in Cranbury and the investors behind them below.
